Develops portable, non-invasive blood testing devices using magnetic resonance spectroscopy to measure metabolites like glucose and lactate directly from the fingertip. This technology eliminates the need for needle pricks, providing real-time metabolic data to enable predictive and personalized healthcare.
Funding
$35.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for blood glucose monitoring rely on invasive finger pricks, causing discomfort and inconvenience for patients, especially those requiring frequent measurements. The lack of continuous, non-invasive monitoring limits the ability to proactively manage metabolic health and prevent complications.
Solution
Synex Medical is developing a non-invasive health monitoring device that uses magnetic resonance spectroscopy to measure blood metabolites, such as glucose and lactate, directly from the fingertip. This technology eliminates the need for needles, providing real-time metabolic data for predictive and personalized healthcare. By applying magnetic fields and radiofrequency pulses, the device excites hydrogen atoms in glucose molecules and measures the emitted energy to determine blood-glucose concentration. The device focuses on blood and interstitial fluid in the dermis to provide accurate and absolute measurements.
Target Audience
The primary target audience includes individuals with diabetes, healthcare providers, and researchers seeking continuous, non-invasive methods for monitoring metabolic health.
Features
- Non-invasive glucose monitoring using magnetic resonance spectroscopy
- Measures blood metabolites, including glucose and lactate, directly from the fingertip
- Portable and compact design for convenient use
- Real-time data acquisition for continuous monitoring
- Low-power radiofrequency pulses target protons in glucose molecules
- Signal processing algorithms filter noise and isolate the glucose signal